Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea

被引：22

作者：

Berman, Arthur L. ^{[1
]}

机构：

[1] Florida Ctr Gastroenterol, Largo, FL USA

来源：

关键词：

D O I：

10.1097/01.mcg.0000225685.37465.e7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：932 / 933

页数：2

共 6 条

Bishara, J ;

Bloch, Y ;

Garty, M ;

Behor, J ;

Samra, Z .

[2]

Boero M B E, 1990, Microbiol Med, V5, P74

[3] Reduced susceptibility of Clostridium difficile to metronidazole [J].

Brazier, JS ;

Fawley, W ;

Freeman, J ;

Wilcox, MH .

[4]

Fekety R, 1997, AM J GASTROENTEROL, V92, P739

Peláez, T ;

Alcalá, L ;

Alonso, R ;

Rodríguez-Créixems, M ;

García-Lechuz, JM ;

Bouza, E .

[6] Treatment of recurrent Clostridium difficile-associated disease [J].

Surawicz, Christina M. .

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (01) :32-38